65 related articles for article (PubMed ID: 21910161)
1. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.
Uhl E; Krimer P; Schliekelman P; Tompkins SM; Suter S
Genes Chromosomes Cancer; 2011 Nov; 50(11):950-67. PubMed ID: 21910161
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species.
Tawa GJ; Braisted J; Gerhold D; Grewal G; Mazcko C; Breen M; Sittampalam G; LeBlanc AK
PLoS Comput Biol; 2021 Sep; 17(9):e1009450. PubMed ID: 34570764
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Y chromosome copy number alterations in non-neoplastic and neoplastic leukocytes of male dogs.
Mochizuki H; Estrada AJ; Boggess M
Vet J; 2024 Apr; 304():106088. PubMed ID: 38412887
[TBL] [Abstract][Full Text] [Related]
4. Characterizing circulating nucleosomes in the plasma of dogs with lymphoma.
Dolan C; Miller T; Jill J; Terrell J; Kelly TK; Bygott T; Wilson-Robles H
BMC Vet Res; 2021 Aug; 17(1):276. PubMed ID: 34399763
[TBL] [Abstract][Full Text] [Related]
5. Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.
Rütgen BC; Willenbrock S; Reimann-Berg N; Walter I; Fuchs-Baumgartinger A; Wagner S; Kovacic B; Essler SE; Schwendenwein I; Nolte I; Saalmüller A; Murua Escobar H
PLoS One; 2012; 7(6):e40078. PubMed ID: 22761949
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
Roode SC; Rotroff D; Richards KL; Moore P; Motsinger-Reif A; Okamura Y; Mizuno T; Tsujimoto H; Suter SE; Breen M
BMC Vet Res; 2016 Sep; 12():207. PubMed ID: 27639374
[TBL] [Abstract][Full Text] [Related]
7. Single-cell T-cell receptor repertoire profiling in dogs.
Hoang MH; Skidmore ZL; Rindt H; Chu S; Fisk B; Foltz JA; Fronick C; Fulton R; Zhou M; Bivens NJ; Reinero CN; Fehniger TA; Griffith M; Bryan JN; Griffith OL
Commun Biol; 2024 Apr; 7(1):484. PubMed ID: 38649520
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of circulating serum microRNAs in dogs with lymphoma.
Fujiwara-Igarashi A; Igarashi H; Mizutani N; Goto-Koshino Y; Takahashi M; Ohno K; Tsujimoto H
Vet J; 2015 Aug; 205(2):317-21. PubMed ID: 26002992
[TBL] [Abstract][Full Text] [Related]
9. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
10. A review on microRNA detection and expression studies in dogs.
Varvil MS; Dos Santos AP
Front Vet Sci; 2023; 10():1261085. PubMed ID: 37869503
[TBL] [Abstract][Full Text] [Related]
11. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
Chakrabortty A; Patton DJ; Smith BF; Agarwal P
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes.
Montaner-Angoiti E; Marín-García PJ; Llobat L
Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766357
[TBL] [Abstract][Full Text] [Related]
13. Identification of canine circulating miRNAs as tumor biospecific markers using Next-Generation Sequencing and Q-RT-PCR.
Agarwal P; Crepps MP; Stahr NA; Kretzschmar WP; Harris HC; Prasad N; Levy SE; Smith BF
Biochem Biophys Rep; 2021 Dec; 28():101106. PubMed ID: 34458596
[TBL] [Abstract][Full Text] [Related]
14. Predicting miRNA-Disease Association Based on Modularity Preserving Heterogeneous Network Embedding.
Peng W; Du J; Dai W; Lan W
Front Cell Dev Biol; 2021; 9():603758. PubMed ID: 34178973
[TBL] [Abstract][Full Text] [Related]
15. A Computational Study of Potential miRNA-Disease Association Inference Based on Ensemble Learning and Kernel Ridge Regression.
Peng LH; Zhou LQ; Chen X; Piao X
Front Bioeng Biotechnol; 2020; 8():40. PubMed ID: 32117922
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling in canine multicentric lymphoma.
Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
[TBL] [Abstract][Full Text] [Related]
17. Expression of blood hepatocyte-derived microRNA-122 in canine multicentric lymphoma with hepatic involvement.
Ramadan ES; Kubesy AA; Baraka TA; Torad FA; Salem SI; Salem NY
Vet Res Commun; 2019 Nov; 43(4):231-238. PubMed ID: 31473888
[TBL] [Abstract][Full Text] [Related]
18. Integrating random walk and binary regression to identify novel miRNA-disease association.
Niu YW; Wang GH; Yan GY; Chen X
BMC Bioinformatics; 2019 Jan; 20(1):59. PubMed ID: 30691413
[TBL] [Abstract][Full Text] [Related]
19. Identification of dysregulated microRNAs in canine malignant melanoma.
Ushio N; Rahman MM; Maemura T; Lai YC; Iwanaga T; Kawaguchi H; Miyoshi N; Momoi Y; Miura N
Oncol Lett; 2019 Jan; 17(1):1080-1088. PubMed ID: 30655868
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
